Mycoplasma pneumoniae COVID-19 Delta Variant Co-Infection Mimicking COVID-19 ARDS.
J Investig Med High Impact Case Rep
; 10: 23247096221129925, 2022.
Article
in English
| MEDLINE | ID: covidwho-2064705
ABSTRACT
The Delta variant of COVID-19 has been associated with severe disease causing a surge in the second half of 2021. Atypical pathogens can be present in those in particular with severe ARDS and can contribute to excess morbidity and mortality. We must maintain a high level of suspicion for these pathogens as this can present an opportunity to dramatically improve the prognosis of a patient with COVID-19 ARDS. However, lend caution to Mycoplasma IgM serology as this can be a false-positive. If suspicion remains high for Mycoplasma pneumoniae infection, sputum polymerase chain reaction (PCR) for M pneumoniae is the gold standard for diagnosis. We present the case of a 42-year-old female with COVID-19 Delta variant presumed ARDS who had co-infection with M pneumoniae confirmed by endotracheal sputum aspirate PCR with rapidly improving oxygenation and extubation within 4 days of effective antibiotic therapy.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Pneumonia, Mycoplasma
/
Respiratory Distress Syndrome
/
Coinfection
/
COVID-19
Type of study:
Case report
/
Diagnostic study
/
Prognostic study
Topics:
Long Covid
/
Variants
Limits:
Adult
/
Female
/
Humans
Language:
English
Journal:
J Investig Med High Impact Case Rep
Year:
2022
Document Type:
Article
Affiliation country:
23247096221129925
Similar
MEDLINE
...
LILACS
LIS